SCHEMBL26685467

SCHEMBL26685467

CC(=O)Nc1cc2c(cn1)c(CO)nn2C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 5/20 0.54
▸ EGFR P00533 2/20 0.42
▸ MAP3K5 Q99683 8/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ CSNK1A1 P48729 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31543230 1.00 MAPK1 (0.54) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL31543182 0.85 MAPK1 (0.54) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL31543309 0.84 MAPK1 (0.53) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL16110613 0.84 MAPK1 (0.64) MAPK1CDK7CLK4
SCHEMBL16110615 0.84 MAPK1 (0.64) MAPK1CDK7CLK4
SCHEMBL31543498 0.83 MAPK1 (0.51) MAPK1EGFRMAP3K5JAK1TYK2
SCHEMBL31543411 0.83 MAPK1 (0.54) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL30632858 0.83 MAPK1 (0.52) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL26685753 0.83 MAPK1 (0.52) MAPK1EGFRMAP3K5MAPTTSHR
SCHEMBL31543078 0.82 MAPK1 (0.53) MAPK1EGFRMAP3K5MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522612-A1 TYK2 INHIBITORS Biogen MA Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220046-A1 TYK2 INHIBITORS BIOGEN MA INC. (US) 2023-11-16 — — WO disclosed
Send feedback